These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20124535)

  • 21. The costs of helping patients with type 1 diabetes achieve tight control.
    Nuovo J; Nuovo J
    Am Fam Physician; 1999 Nov; 60(7):1914, 1920-1. PubMed ID: 10569496
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucose lowering and diabetes prevention: are they the same?
    Tuomilehto J; Wareham N
    Lancet; 2006 Oct; 368(9543):1218-9. PubMed ID: 17027710
    [No Abstract]   [Full Text] [Related]  

  • 23. Implications of the diabetes control and complications trial. American Diabetes Association.
    J Fla Med Assoc; 1998 Aug; 85(2):22-4. PubMed ID: 9782715
    [No Abstract]   [Full Text] [Related]  

  • 24. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 25. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
    Sherman FT
    Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuropathy, retinopathy, and glucose-lowering treatments.
    Bloomgarden ZT
    Diabetes Care; 2010 Jun; 33(6):e73-8. PubMed ID: 20508223
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diabetic polyneuropathy: considerations on 100 cases].
    Naim U; Marasco A
    Clin Ter; 1980 Mar; 92(5):513-31. PubMed ID: 7004751
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment intensification in patients with type 2 diabetes.
    Barnett AH
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():iii. PubMed ID: 18435667
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gastrointestinal motility disorders and therapy. How diabetes paralyzes the intestine].
    MMW Fortschr Med; 2005 Feb; 147(5):8. PubMed ID: 15766015
    [No Abstract]   [Full Text] [Related]  

  • 30. [Differential diagnosis of insulin- and noninsulin-dependent diabetes mellitus--are there therapeutic implications?].
    Tappy L; Fröhlich FE
    Praxis (Bern 1994); 1994 Dec; 83(50):1406-9. PubMed ID: 7801016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes.
    Fujita Y; Fukushima M; Suzuki H; Taniguchi A; Nakai Y; Kuroe A; Yasuda K; Hosokawa M; Yamada Y; Inagaki N; Seino Y
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e16-9. PubMed ID: 18262304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive therapy of type 2 diabetes (ACCORD trial) (OCTOBER 2008).
    Najman DM
    Cleve Clin J Med; 2009 Feb; 76(2):83; author reply 83-4. PubMed ID: 19188472
    [No Abstract]   [Full Text] [Related]  

  • 33. [Painful polyneuropathy in type I diabetes: intermediate insulin-pump therapy].
    Bergis K; Otto K; Mann M
    Dtsch Med Wochenschr; 1986 Mar; 111(12):477-8. PubMed ID: 3948715
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia.
    Halawa MR; Karawagh A; Zeidan A; Mahmoud AE; Sakr M; Hegazy A
    Curr Med Res Opin; 2010 Feb; 26(2):337-43. PubMed ID: 19968592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoglycemic drugs.
    Stehling L
    Clin Anesth; 1974; 10(1):233-47. PubMed ID: 4598996
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential flaws and biases in a randomized controlled trial (RCT) of insulin determir vs. insulin glargine by Pieber and colleagues.
    Alcolado J; Poole CD; Peters JR; Currie CJ
    Diabet Med; 2008 Jan; 25(1):115-6. PubMed ID: 18199142
    [No Abstract]   [Full Text] [Related]  

  • 37. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients.
    Dabby R; Sadeh M; Lampl Y; Gilad R; Watemberg N
    Biomed Pharmacother; 2009 Dec; 63(10):707-9. PubMed ID: 18848759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Insulin Options for Diabetic Patients.
    Van Klompenburg E; Heins JR
    S D Med; 2016 Feb; 69(2):84-5. PubMed ID: 26999916
    [No Abstract]   [Full Text] [Related]  

  • 40. [Is an intensive glycaemic control beneficial in diabetes type 2?].
    Martin S
    Dtsch Med Wochenschr; 2011 Sep; 136(39):1940. PubMed ID: 21948602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.